Search results
Results From The WOW.Com Content Network
South Texas Research Institute, Edinburg, Texas. 1,019 likes · 2 talking about this · 361 were here. South Texas Research Institute (STRI) is a physician-led, patient-centered clinical research site...
South Texas Research Institute (STRI) is a private clinical research site network located in the Rio Grande Valley with sites in Edinburg and Brownsville, Texas. Currently focused on...
Meet the accomplished senior management team at Pinnacle committed to provide clinical trial opportunities to all diverse populations.
Pinnacle Clinical Research, part of the LongueVue Capital portfolio, completed its acquisition of the South Texas Research Institute (STRI), which is known for its clinical research of...
South Texas Research Institute. medical research institute (956) 284-6353 Schedule an Appointment. Home; Clinical Trials. NASH; Fibroscan; About STRI; Our Team; FAQs; Fibroscan; Partners; Testimonials; Contact; Facebook page opens in new window Instagram page opens in new window. Home; Clinical Trials.
South Texas Research Institute. medical research institute (956) 284-6353 Schedule an Appointment. Home; Clinical Trials. NASH; Fibroscan; About STRI; Our Team; FAQs; Fibroscan; Partners; Testimonials; Contact; Facebook page opens in new window Instagram page opens in new window. Home; Clinical Trials.
STRI conducts clinical trials yielding results that empower medical professionals and patients to make informed health care decisions by advancing medical knowledge, promoting new and promising treatments, and facilitating access to otherwise unobtainable medications.
South Texas Research Institute - A Pinnacle Entity. 717 N. Expressway 77/83 Suite 6-9. Brownsville, TX 78520. (956) 468-3360.
SAN ANTONIO, Jan. 10, 2023 /PRNewswire/ -- Pinnacle Clinical Research ("Pinnacle"), a portfolio company of LongueVue Capital ("LVC") and a leading site organization specializing in complex...
South Texas Research Institute is a patient-centered clinical research project that aims to make Hispanics, the fastest-growing minority demographic, more aware of their possibilities for clinical trials.